Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents

Kaohsiung Journal of Medical Sciences

Volumn 28, Issue 6, 2012, Pages 306-315

  Chen, Tun Chieh ^a,c   Chen, Yen Hsu ^b,c   Chen, Yee Chun ^d,e   Lu, Po Liang ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Candida glabrata; Cross resistance; Triazole

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CORRELATION ANALYSIS; DRUG EXPOSURE; GENOTYPING TECHNIQUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RECEIVER OPERATING CHARACTERISTIC;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 84861602388     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2011.11.011     Document Type: Article

References (40)

1. Y.C. Chen, S.C. Chang, C.C. Sun, L.S. Yang, W.C. Hsieh, and K.T. Luh Secular trends in the epidemiology of noscomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993 Infect Control Hosp Epidemiol 18 1997 369 375
2. S.Y. Ruan, and P.R. Hsueh Invasive candidiasis: an overview from Taiwan J Formos Med Assoc 108 2009 443 451
3. Centers for Disease Control, R.O.C. (Taiwan) Statistics of Communicable Diseases and Surveillance Report 2008 Taipei City: Centers for Disease Control R.O.C. (Taiwan) 40-44
4. Y.L. Yang, A.H. Wang, C.W. Wang, W.T. Cheng, S.Y. Li, and H.J. Lo Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan surveillance of antimicrobial resistance of yeasts 2006 Diag Microbiol Infect Dis 61 2008 175 180
5. P.R. Hsueh, Y.J. Lau, Y.C. Chuang, J.H. Wan, W.K. Huang, and J.M. Shyr Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003 Antimicrob Agents Chemother 49 2005 512 517
6. S.Y. Ruan, C.C. Chu, and P.R. Hsueh In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates Antimicrob Agents Chemother 52 2008 2919 2922
7. T.C. Chen, Y.H. Chen, J.J. Tsai, C.F. Peng, P.L. Lu, and K. Chang Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan J Microbiol Immunol Infect 38 2005 200 210 (Pubitemid 40992163)
8. A. Wanger, K. Mills, P.W. Nelson, and J.H. Rex Comparison of Etest and National committee for clinical laboratory standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates Antimicrob Agents Chemother 39 1995 2520 2522
9. M.A. Pfaller, S.A. Messer, A. Karlsson, and A. Bolmström Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media J Clin Microbiol 36 1998 2586 2589 (Pubitemid 28380960)
10. M.A. Pfaller, S.A. Messer, A. Houston, K. Mills, A. Bolmstrom, and R.N. Jones Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media J Clin Microbiol 38 2000 3715 3717
11. National Committee for Clinical Laboratory Standards Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved standard 2nd ed. 2002 National Committee for Clinical Laboratory Standards Wayne, PA
12. M.A. Pfaller, D. Andes, D.J. Diekema, A. Espinel-Ingroff, and D. Sheehan CLSI subcommittee for antifungal susceptibility testing. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods Drug Resist Updat 13 2010 180 195
13. M.A. Pfaller, D.J. Diekema, D. Andes, M.C. Arendrup, S.D. Brown, and S.R. Lockhart Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria Drug Resist Updat 14 2011 164 176
14. National Committee for Clinical Laboratory Standards Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts 3rd ed. 2008 National Committee for Clinical Laboratory Standards Wayne, PA Approved standard
15. M.H. Nguyen, C.J. Clancy, V.L. Yu, Y.C. Yu, A.J. Morris, and D.R. Snydman Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia J Infect Dis 177 1998 425 430 (Pubitemid 28063769)
16. J.H. Rex, M.A. Pfaller, T.J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, and M.A. Ghannoum Antifungal susceptibility testing: practical aspects and current challenges Clin Microbiol Rev 14 2001 643 658 (Pubitemid 32979625)
17. P.L. Lu, P.R. Hsueh, Y.C. Chen, L.J. Teng, S.C. Chang, and K.T. Luh Clones of Lactobacillus casei and Torulopsis glabrata associated with recurrent abdominal wall abscess J Formos Med Assoc 98 1999 356 360
18. W.E. Trick, S.K. Fridkin, J.R. Edwards, R.A. Hajjeh, and R.P. Gaynes National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999 Clin Infect Dis 35 2002 627 630
19. R. McMullan, R. McClurg, J. Xu, J.E. Moore, B.C. Millar, and M. Crowe Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between january 1984 and december 2000 J Infect 45 2002 25 28 (Pubitemid 36104803)
20. Y.L. Yang, Y.A. Ho, H.H. Cheng, and H.J. Lo TSARY Hospitals. Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan Epidemiol Infect 133 2005 325 330 (Pubitemid 40439313)
21. Y.L. Yang, H.H. Cheng, Y.A. Ho, C.F. Hsiao, and H.J. Lo Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan J Microbiol Immunol Infect 36 2003 187 191
22. M.E. Klepser Antifungal resistance among Candida species Pharmacotherapy 21 2001 124S 132S (Pubitemid 32727041)
23. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamin Jr., T.F. Calandra, and J.E. Edwards Jr. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America Clin Infect Dis 48 2009 503 535
24. B. Posteraro, M. Sanguinetti, B. Fiori, M. La Sorda, T. Spanu, and D. Sanglard Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes J Antimicrob Chemother 58 2006 458 461 (Pubitemid 44294967)
25. S.S. Magill, C. Shields, C.L. Sears, M. Choti, and W.G. Merz Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy J Clin Microbiol 44 2006 529 535 (Pubitemid 43222248)
26. A.A. Panackal, J.L. Gribskov, J.F. Staab, K.A. Kirby, M. Rinaldi, and K.A. Marr Clinical significance of azole antifungal drug cross-resistance in Candida glabrata J Clin Microbiol 44 2006 1740 1743 (Pubitemid 43726263)
27. B. Posteraro, M. Tumbarello, M. La Sorda, T. Spanu, E.M. Trecarichi, and F. De Bernardis Azole resistance of Candida glabrata in a case of recurrent fungemia J Clin Microbiol 44 2006 3046 3047 (Pubitemid 44228619)
28. M. Sanguinetti, B. Posteraro, B. Fiori, S. Ranno, R. Torelli, and G. Fadda Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance Antimicrob Agents Chemother 49 2005 668 679 (Pubitemid 40175679)
29. A. Borst, M.T. Raimer, D.W. Warnock, C.J. Morrison, and B.A. Arthington-Skaggs Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole Antimicrob Agents Chemother 49 2005 783 787 (Pubitemid 40175697)
30. J. Cernicka, and J. Subik Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis Int J Antimicrob Agents 27 2006 403 408
31. M. Tumbarello, M. Sanguinetti, E.M. Trecarichi, M. La Sorda, M. Rossi, and E. de Carolis Fungemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome J Antimicrob Chemother 62 2008 1379 1385
32. I. Lee, N.O. Fishman, T.E. Zaoutis, K.H. Morales, M.G. Weiner, and M. Synnestvedt Risk factors Risk factors for fluconazole-resistant Candida glabrata bloodstream infections Arch Intern Med 169 2009 379 383
33. I. Lee, T.E. Zaoutis, N.O. Fishman, K.H. Morales, I. Nachamkin, and E. Lautenbach Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact on control group selection on characterizing the association between previous fluconazole use and fluconazole resistance Am J Infect Control 38 2010 456 460
34. J.S. Wang, S.Y. Li, Y.L. Yang, H.H. Chou, and H.J. Lo Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan J Med Microbiol 56 2007 650 653
35. E.C. van Asbeck, Y.C. Huang, A.N. Markham, K.V. Clemons, and D.A. Stevens Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies Mycopathologia 164 2007 287 293 (Pubitemid 47622127)
36. S.Y. Li, Y.L. Yang, Y.H. Lin, H.C. Ko, A.H. Wang, and K.W. Chen Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006 Microb Drug Resist 15 2009 205 210
37. M.A. Pfaller, D.J. Diekema, J.H. Rex, A. Espinel-Ingroff, E.M. Johnson, and D. Andes Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints J Clin Microbiol 44 2006 819 826
38. M.A. Pfaller, S.A. Messer, L. Boyken, C. Rice, S. Tendolkar, and R.J. Hollis Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp J Clin Microbiol 42 2004 3137 3141 (Pubitemid 38938070)
39. M.A. Pfaller, S.A. Messer, L. Boyken, C. Rice, S. Tendolkar, and R.J. Hollis Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. tested by clinical and laboratory standards institute-recommended broth microdilution methods J Clin Microbiol 45 2007 70 75 (Pubitemid 46106408)
40. M.A. Pfaller, S.A. Messer, L. Boyken, S. Tendolkar, R.J. Hollis, and D.J. Diekema Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program J Clin Microbiol 46 2008 551 559 (Pubitemid 351231301)